CAR T-cell Products Shine, Reveal New Insights
Real-world experience with chimeric antigen receptor (CAR) T-cell therapies for large B-cell lymphomas compares favorably with experience in commercial and
Read more
Real-world experience with chimeric antigen receptor (CAR) T-cell therapies for large B-cell lymphomas compares favorably with experience in commercial and
Read moreNEW YORK (Reuters Health) – The monoclonal antibody ustekinumab (Stelara, Janssen) appears to be at least as effective against ulcerative
Read more